The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 21, 2022
Filed:
Jun. 15, 2017
Applicants:
Inozyme Pharma, Inc., Boston, MA (US);
Westfaelische Wilhelms-universitaet Muenster, Münster, DE;
Inventors:
Yan Yan, Cheshire, CT (US);
Anumeha Shah, Cheshire, CT (US);
Ashmita Saigal, Stamford, CT (US);
Herman Griffin, Waterford, CT (US);
Susan Faas McKnight, Old Lyme, CT (US);
Andre Marozsan, Milford, CT (US);
Kim Askew, Lincoln, MA (US);
Yvonne Nitschke, Münster, DE;
Frank Rutsch, Münster, DE;
Assignees:
Inozyme Pharma, Inc., Boston, MA (US);
Westfaelische Wilhelms-Universitaet Muenster, Münster, DE;
Primary Examiner:
Int. Cl.
CPC ...
A61P 9/10 (2006.01); C12N 9/16 (2006.01); A61K 38/46 (2006.01); A01K 67/027 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A01K 67/0271 (2013.01); A01K 2227/105 (2013.01); A01K 2267/03 (2013.01); A61K 45/06 (2013.01); C07K 2319/30 (2013.01); C12Y 301/04001 (2013.01);
Abstract
The present invention provides a method of treating myointimal proliferation by administering a recombinant human soluble ectonucleotide pyrophosphatase phosphodiesterase (hsNPP1), active fragment or fusion protein thereof.